A pragmatic view on pragmatic trials

Dialogues in Clinical Neuroscience - Tập 13 Số 2 - Trang 217-224 - 2011
Nikolaos A. Patsopoulos1
1Division of Genetics, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Program in Translational Neuropsychiatrie Genomics, Institute for the Neurosciences, Department of Neurology, Brigham & Women's Hospital, Boston, Massachusetts, USA; Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Grimes DA., 2002, Lancet., 359, 248, 10.1016/S0140-6736(02)07451-2

Zwarenstein M., 2006, J Clin Epidemiol., 59, 1125, 10.1016/j.jclinepi.2006.05.010

Weiss NS., 2008, Arch Intern Med., 168, 133, 10.1001/archinternmed.2007.30

Treweek S., 2009, Trials., 10, 37, 10.1186/1745-6215-10-37

Schwartz D., 1967, J Chronic Dis., 20, 637, 10.1016/0021-9681(67)90041-0

Tunis SR., 2003, JAMA., 290, 1624, 10.1001/jama.290.12.1624

Maclure M., 2009, J Clin Epidemiol., 62, 476, 10.1016/j.jclinepi.2008.06.021

Gartlehner G., 2006, J Clin Epidemiol., 59, 1040, 10.1016/j.jclinepi.2006.01.011

Thorpe KE., 2009, J Clin Epidemiol., 62, 464, 10.1016/j.jclinepi.2008.12.011

Koppenaal T., 2011, J Clin Epidemiol.

Tosh G., 2011, Dialogues Clin Neurosci., 13, 209, 10.31887/DCNS.2011.13.2/gtosh

Charlton BG., 1994, Earn Pract., 11, 243

Glasgow RE., 2005, Med Care., 43, 551, 10.1097/01.mlr.0000163645.41407.09

Macpherson H., 2004, Complement Ther Med., 12, 136, 10.1016/j.ctim.2004.07.043

Prioritization. CoCR., 2009, Institute of Medicine Initial National Priorities for Compaiative Effectiveness Research. Washington, DC: National Academy Press,

Rothwell PM., 2005, Lancet., 365, 82, 10.1016/S0140-6736(04)17670-8

Masuhr F., 1998, Stroke., 29, 339, 10.1161/01.STR.29.2.339

Wood L., 2008, BMJ., 336, 601, 10.1136/bmj.39465.451748.AD

Odgaard-Jensen J., 2011, Cochrane Database Syst Rev., 4, MR000012

Pildal J., 2007, Int J Epidemiol., 36, 847, 10.1093/ije/dym087

March J., 2010, Neuropsychopharmacology., 35, 2491, 10.1038/npp.2010.115

Relton C., 2010, BMJ., 340, c1066, 10.1136/bmj.c1066

loannidis JPA., 2006, Lancet., 368, 1470, 10.1016/S0140-6736(06)69615-3

Lathyris DN., 2010, Eur J Clin invest., 40, 172, 10.1111/j.1365-2362.2009.02240.x

Goldberg NH., 2011, JAMA., 305, 1786, 10.1001/jama.2011.539

Group AOaCftACR. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)., 2002, JAMA., 288, 2981, 10.1001/jama.288.23.2981

Pocock SJ., 2004, BMJ., 329, 883, 10.1136/bmj.38250.571088.55

Lawlor DA., 2004, lancet., 363, 1724, 10.1016/S0140-6736(04)16260-0

Djulbegovic M., 2011, JAMA., 305, 298, 10.1001/jama.2010.2013

Karanicolas PJ., 2009, Evid Based Med., 14, 130, 10.1136/ebm.14.5.130-b

Patsopoulos NA., 2005, JAMA., 293, 2362, 10.1001/jama.293.19.2362

Lu G., 2004, Stat Med., 23, 3105, 10.1002/sim.1875

Cipriani A., 2009, Lancet., 373, 746, 10.1016/S0140-6736(09)60046-5

Zwarenstein M., 2008, BMJ., 337, a2390, 10.1136/bmj.a2390